Eastgate Biotech Corp Price Prediction
| ETBIDelisted Stock | USD 0 0.00 0.00% |
Oversold Vs Overbought
0
Oversold | Overbought |
Using Eastgate Biotech hype-based prediction, you can estimate the value of Eastgate Biotech Corp from the perspective of Eastgate Biotech response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Eastgate Biotech to buy its stock at a price that has no basis in reality. In that case, they are not buying Eastgate because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Eastgate Biotech after-hype prediction price | USD 0.005625 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as delisted stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Eastgate |
Eastgate Biotech After-Hype Price Prediction Density Analysis
As far as predicting the price of Eastgate Biotech at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Eastgate Biotech or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Eastgate Biotech, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Eastgate Biotech Estimiated After-Hype Price Volatility
In the context of predicting Eastgate Biotech's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Eastgate Biotech's historical news coverage. Eastgate Biotech's after-hype downside and upside margins for the prediction period are 0.00 and 0.01, respectively. We have considered Eastgate Biotech's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Eastgate Biotech is very steady at this time. Analysis and calculation of next after-hype price of Eastgate Biotech Corp is based on 3 months time horizon.
Eastgate Biotech Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Eastgate Biotech is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Eastgate Biotech backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Delisted Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Eastgate Biotech, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.00 | 0.00 | 0.00 | 0.00 | 1 Events / Month | 5 Events / Month | Very soon |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
0 | 0.01 | 25.00 |
|
Eastgate Biotech Hype Timeline
Eastgate Biotech Corp is currently traded for 0. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Eastgate is forecasted to increase in value after the next headline, with the price projected to jump to 0.005625 or above. The average volatility of media hype impact on the company the price is insignificant. The price growth on the next news is forecasted to be 25.0%, whereas the daily expected return is currently at 0.0%. The volatility of related hype on Eastgate Biotech is about 0.0%, with the expected price after the next announcement by competition of 0.00. Eastgate Biotech Corp currently holds 1.67 M in liabilities. Eastgate Biotech Corp has a current ratio of 0.02, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about Eastgate Biotech's use of debt, we should always consider it together with its cash and equity.Given the investment horizon of 90 days the next forecasted press release will be very soon. Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.Eastgate Biotech Related Hype Analysis
Having access to credible news sources related to Eastgate Biotech's direct competition is more important than ever and may enhance your ability to predict Eastgate Biotech's future price movements. Getting to know how Eastgate Biotech's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Eastgate Biotech may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| ICCH | ICC Holdings | 0.38 | 7 per month | 0.41 | (0.21) | 0.83 | (0.60) | 3.36 | |
| J | Jacobs Solutions | (1.73) | 8 per month | 1.49 | 0.05 | 2.41 | (1.47) | 9.97 | |
| GOCO | GoHealth | (0.84) | 7 per month | 3.08 | 0.15 | 8.03 | (5.47) | 17.48 | |
| NODK | NI Holdings | 0.17 | 4 per month | 1.29 | 0.05 | 2.09 | (2.04) | 6.11 | |
| SPNT | Siriuspoint | (0.15) | 6 per month | 1.62 | 0.01 | 2.68 | (2.74) | 13.03 | |
| ELVA | Electrovaya Common Shares | (0.06) | 5 per month | 2.64 | 0.09 | 6.47 | (4.05) | 20.02 | |
| ALDFU | Aldel Financial II | (0.03) | 4 per month | 0.07 | (1.22) | 0.20 | (0.10) | 0.40 |
Eastgate Biotech Additional Predictive Modules
Most predictive techniques to examine Eastgate price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Eastgate using various technical indicators. When you analyze Eastgate charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Eastgate Biotech Predictive Indicators
The successful prediction of Eastgate Biotech stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Eastgate Biotech Corp, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Eastgate Biotech based on analysis of Eastgate Biotech hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Eastgate Biotech's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Eastgate Biotech's related companies.
Story Coverage note for Eastgate Biotech
The number of cover stories for Eastgate Biotech depends on current market conditions and Eastgate Biotech's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Eastgate Biotech is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Eastgate Biotech's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
Other Consideration for investing in Eastgate Stock
If you are still planning to invest in Eastgate Biotech Corp check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Eastgate Biotech's history and understand the potential risks before investing.
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges |